ESG Recognizes Apcera As The Most Secure and Trustworthy

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
ESG Recognizes Apcera As The Most Secure and Trustworthy Container Management Platform

SAN FRANCISCO, CA--(Marketwired - Oct 25, 2016) -    Apcera , the leader in enterprise container management, today announced that Enterprise Strategy Group (ESG) has published a new report titled, "Apcera: A Container Management Platform Built for Secure and Trustworthy Operations." ESG describes the Apcera Platform as a "container management platform that is designed for legacy and modern applications with security and trustworthy operations in mind," and details Apcera's suitability for production as well as its use of policy and governance, differentiating it from other solutions on the market. 

The report, authored by Daniel Conde, analyst at ESG, states, "Apcera has understood from the beginning that running applications with trust is critical for production environments. It also addresses key modern trends such as loosely coupled, micro-service-based applications, use of on- or off-premises platforms, and the need to run legacy Linux-based workloads. However, trust delivered by security, compliance, and performance is at the heart of the platform and that makes it a pragmatic approach."

The report goes on to say "Apcera realizes that the focus of attention is at the application framework level, so it can deliver a platform with a focus on policy without re-creating a low-level infrastructure platform, which are provided by third parties such as Linux or public cloud platforms. This combination creates a distinctive offering. Even if major public cloud providers introduce policy capabilities into their platforms, enterprises will seek either a multi-cloud solution or a hybrid (on-premises and off-premises) cloud solution, and a common platform such as Apcera will provide for flexibility in choosing several underlying platforms without a significant redeployment cost."

"Apcera has taken an enterprise-first approach to container management, embracing both cloud-native and legacy applications," said Mark Thiele, chief strategy officer at Apcera. "The ESG report is a strong validation of our strategy and underscores our commitment to delivering a secure and production-ready solution for container management that truly addresses the needs of enterprise IT."

The Apcera Platform is the market leading enterprise-grade container management platform -- driven by security and policy -- that gives IT leaders the confidence and control to drive innovation and go faster, securely. Apcera is unique in that it allows for not just the containerization of cloud-native applications, but legacy Linux-based, x86 applications as well. By embracing a range of enterprise applications, Apcera is the only true enterprise-grade container management platform on the market today. 

Download a complimentary copy of the report here .

Helpful Links

Suggested Tweet: @esg_global recognizes @Apcera as the most secure and trustworthy container management platform  bit.ly/2egSv5q #containermanagement

About Apcera Apcera is the market leading enterprise-grade container management platform, driven by security and policy, that gives IT leaders the confidence and control to drive innovation and move faster, securely. Built for cloud-native as well as legacy applications, Apcera lets IT teams containerize, deploy, orchestrate and govern a vast range of workloads across on-premises, cloud and hybrid environments. Fully integrated and completely turnkey, only Apcera offers industry-leading agility and time-to-value without sacrificing security or control.  Apcera enables key enterprise use cases including deploying Docker in production securely and at scale, legacy application modernization and hybrid cloud mobility. Global 2000 companies use Apcera to lower CapEx and OpEx, improve time to market and reduce risk. 

Apcera is headquartered in San Francisco. For more information, visit http://www.apcera.com , read the company's blog or follow on Twitter: @apcera .

Media Contact: Tanya Carlsson Kulesa Faul for Apcera (707) 529-6139 Email Contact

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 62

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 299

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 351

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 343

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Cultural Tech Fusion: The Asia-Pacific Way Forward

Updated Category News Views 29

A High-Tech Twist on Traditional Culture You ever walk into a room and see a robot perform kung fu? I'll admit, it caught me off guard at first. But that's exactly what happened at the "Enduring Heritage, Harmonious Asia-Pacific" special exhibition in Shenzhen. With all the usual high-ranking execs and cultural bigwigs there, nobody expected a showcase where Wing Chun...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 123

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 69

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 250

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 119

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 456

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading

Top 5 Most Recently Viewed Articles

Brazil Potash Secures $75 Million Equity Line for Growth

Updated Category News Views 167

Brazil Potash Secures Key Funding for Autazes Project Brazil Potash Corp. (“Brazil Potash” or the “Company”) (NYSE American: GRO), a prominent player in mineral development focused on potash mining, has recently finalized a significant agreement establishing an equity line of credit (ELOC) with Alumni Capital LP. This collaboration signals a crucial step in...

Continue Reading
AGCO Completes Major Strategic Shift Transforming Business Focus

Updated Category News Views 101

AGCO Completes Divestiture of Grain & Protein Business AGCO Corporation (NYSE: AGCO), a leading firm in agricultural machinery and precision ag technology, has finalized the sale of the majority of its Grain & Protein business to American Industrial Partners (AIP) in an all-cash deal valued at around $700 million. This significant transition emphasizes AGCO's focus on...

Continue Reading
Vincent Bouatou Takes the Helm as CTO at IDEMIA Public Security

Updated Category News Views 64

Vincent Bouatou Appointed as Chief Technology Officer With a wealth of experience in the technology sector, Vincent Bouatou has been officially announced as the Chief Technology Officer (CTO) of IDEMIA Public Security. His extensive background in driving technological innovations positions him to make significant strides in the biometric technology industry. Driving...

Continue Reading
MedX Holdings, Inc. Reaches New Heights in Q1 Revenue Growth

Updated Category News Views 171

MedX Holdings, Inc. Reports Extraordinary Q1 Revenue Gains MedX Holdings, Inc. (OTC: MEDH) is delighted to share its impressive financial results for the first quarter of 2025. With record revenue levels and strategic advancements, this milestone reflects the company's commitment to becoming a prominent player in cannabis retail, technology, and franchise development....

Continue Reading
Erste Group Upgrades WW Grainger Stock Amid Positive Outlook

Updated Category News Views 74

Erste Group upgraded WW Grainger (NYSE: GWW) from Hold to Buy back in mid-2024, showing that the desks had a new favorite. With a return on equity at a whopping 59%, Grainger's performance left many competitors in the dust, making it a must-watch stock for anyone looking to get into industrial supply chains. What's Driving the Upgrade? The reasons behind this rating shift...

Continue Reading